Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan;56(1):74-83.
doi: 10.1016/j.amepre.2018.07.038.

Implementation of Strategies to Improve Human Papillomavirus Vaccine Coverage: A Provider Survey

Emily B Walling  1 , Sherry Dodd  2 , Neil Bobenhouse  2 , Evelyn Cohen Reis  3 , Randy Sterkel  2 , Jane Garbutt  4
Affiliations

Implementation of Strategies to Improve Human Papillomavirus Vaccine Coverage: A Provider Survey

Emily B Walling et al. Am J Prev Med. 2019 Jan.

Abstract

Introduction: Human papillomavirus (HPV) vaccine coverage in the U.S. is persistently suboptimal, despite research describing barriers to vaccination and strategies to increase vaccination coverage. The objective was to assess providers' approach to the HPV vaccine and their implementation of strategies to increase HPV vaccination coverage. The hypothesis was that adoption of improvement measures to address underuse of the HPV vaccine has not occurred.

Methods: Community pediatric providers from two Midwestern practice-based research networks completed self-administered electronic surveys. Data were collected over 6 months in 2015 and organized and analyzed in 2016.

Results: There were 100 providers that participated. Despite agreement with national recommendations, some providers delayed their recommendation until the adolescent was older and many reported missed vaccination opportunities. Many providers experienced parental concerns including safety of the HPV vaccine, belief their child was not at risk of HPV infection, and their child's resistance to receiving multiple shots. Providers identified the following as barriers to adherence to Advisory Committee on Immunization Practices guidelines: bad publicity of the HPV vaccine, information about the HPV vaccine on the web, and a lack of a follow-up system for those who delayed HPV vaccine initiation. Approximately half of the participants had implemented strategies to address these barriers beyond offering immunization-only appointments.

Conclusions: Participants were aware of barriers to HPV vaccine use, but many had not adopted a systematic approach to increase vaccine coverage. A better understanding of the challenges facing providers to adopting improvement measures and a strategy to address barriers to implementation are needed to improve HPV coverage.

PubMed Disclaimer

References

    1. Jemal A, Simard EP, Dorell C, et al. Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)–associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105(3):175–201. 10.1093/jnci/djs491. - DOI - PMC - PubMed
    1. Office of Disease Prevention and Health Promotion, HHS. Immunization and Infectious Diseases, Healthy People 2020. www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infe.... Accessed March 6, 2016.
    1. Walker TY, Elam-Evans LD, Singleton JA, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years – United States, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(33):874–882. 10.15585/mmwr.mm6633a2. - DOI - PMC - PubMed
    1. FUTURE I/II Study Group, Dillner J, Kjaer SK, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ. 2010;341:c3493 10.1136/bmj.c3493. - DOI - PMC - PubMed
    1. Szilagyi PG, Humiston SG, Gallivan S, Albertin C, Sandler M, Blumkin A. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch Pediatr Adolesc Med. 2011;165(6):547–553. 10.1001/archpediatrics.2011.73. - DOI - PubMed

Publication types

Substances